Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

H. Lundbeck A/S

HLBBFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$6.21
$0.11(1.80%)
U.S. Market opens in 7h 52m

H. Lundbeck A/S Fundamental Analysis

H. Lundbeck A/S (HLBBF) shows strong financial fundamentals with a PE ratio of 12.22, profit margin of 12.96%, and ROE of 12.93%. The company generates $19.7B in annual revenue with strong year-over-year growth of 10.51%.

Key Strengths

Operating Margin21.42%
Cash Position55.62%
PEG Ratio-0.12

Areas of Concern

No major concerns flagged.
We analyze HLBBF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 62.1/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
62.1/100

We analyze HLBBF's fundamental strength across five key dimensions:

Efficiency Score

Weak

HLBBF struggles to generate sufficient returns from assets.

ROA > 10%
5.92%

Valuation Score

Excellent

HLBBF trades at attractive valuation levels.

PE < 25
12.22
PEG Ratio < 2
-0.12

Growth Score

Excellent

HLBBF delivers strong and consistent growth momentum.

Revenue Growth > 5%
10.51%
EPS Growth > 10%
37.23%

Financial Health Score

Excellent

HLBBF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.48
Current Ratio > 1
1.44

Profitability Score

Weak

HLBBF struggles to sustain strong margins.

ROE > 15%
12.93%
Net Margin ≥ 15%
12.96%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is HLBBF Expensive or Cheap?

P/E Ratio

HLBBF trades at 12.22 times earnings. This suggests potential undervaluation.

12.22

PEG Ratio

When adjusting for growth, HLBBF's PEG of -0.12 indicates potential undervaluation.

-0.12

Price to Book

The market values H. Lundbeck A/S at 1.57 times its book value. This may indicate undervaluation.

1.57

EV/EBITDA

Enterprise value stands at 4.52 times EBITDA. This is generally considered low.

4.52

How Well Does HLBBF Make Money?

Net Profit Margin

For every $100 in sales, H. Lundbeck A/S keeps $12.96 as profit after all expenses.

12.96%

Operating Margin

Core operations generate 21.42 in profit for every $100 in revenue, before interest and taxes.

21.42%

ROE

Management delivers $12.93 in profit for every $100 of shareholder equity.

12.93%

ROA

H. Lundbeck A/S generates $5.92 in profit for every $100 in assets, demonstrating efficient asset deployment.

5.92%

Following the Money - Real Cash Generation

Operating Cash Flow

H. Lundbeck A/S produces operating cash flow of $3.91B, showing steady but balanced cash generation.

$3.91B

Free Cash Flow

H. Lundbeck A/S generates strong free cash flow of $3.47B, providing ample flexibility for dividends, buybacks, or growth.

$3.47B

FCF Per Share

Each share generates $4.38 in free cash annually.

$4.38

FCF Yield

HLBBF converts 13.94% of its market value into free cash.

13.94%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

12.22

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.12

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.57

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.27

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.48

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.44

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.13

vs 25 benchmark

ROA

Return on assets percentage

0.06

vs 25 benchmark

ROCE

Return on capital employed

0.12

vs 25 benchmark

How HLBBF Stacks Against Its Sector Peers

MetricHLBBF ValueSector AveragePerformance
P/E Ratio12.2229.78 Better (Cheaper)
ROE12.93%792.00% Weak
Net Margin12.96%-23280.00% (disorted) Strong
Debt/Equity0.480.25 Weak (High Leverage)
Current Ratio1.444.60 Neutral
ROA5.92%-18077.00% (disorted) Weak

HLBBF outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews H. Lundbeck A/S's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-74.60%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

-76.38%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-74.45%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ